Senior insider sale
ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$250.0K
9.62K shares
What this filing means
OWEN KATEY EINTERZ plans to sell 9.62K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $250.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/26/2026ACC: 0001950047-26-008709
Director
Since Mar 2021
9.62K
Shares to sell
$250.0K
Approx. market value
9.62K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock
Not Applicable
3/4/2025
1.82KRestricted Stock
Not Applicable
1/26/2023
6.69KRestricted Stock
Not Applicable
3/17/2022
1.11KTotal acquired9.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2025 | Restricted Stock Not Applicable | 1.82K | — |
1/26/2023 | Restricted Stock Not Applicable | 6.69K | — |
3/17/2022 | Restricted Stock Not Applicable | 1.11K | — |
| Total | 9.62K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.62K
Market value
$250.0K
8/26/2026
Total
Units
9.62K
Value
$250.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/26/2026 | 9.62K | $250.0K | NASDAQ | Planned |
| Total | 9.62K | $250.0K | ||